Lundbeckfonden Ventures — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Tiburio TherapeuticsinDec 2018
BiotechCambridge, US
James G. McArthur(Executive Officer)Abraham N. Ceesay(Executive Officer)Christoph M. Adams(Executive Officer, Director)
BoardMette Kirstine Agger(Director)David Mott(Director)Sandip Agarwala(Director)
Co-investorsAlexandriaLongitude CapitalNew Enterprise Associates (NEA)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.